GlassScriptPhysician profile
Lauren Lan Woolbert
NPI 1043622103
$6,456.72
in general payments reported to CMS, 2019-2025
51 companies · $879 in 2025
The $879 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $372 · 2021: $707 · 2022: $999 · 2023: $1,098 · 2024: $1,270 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,215 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,214.95 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $820.00 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $792.87 | 2019-2025 | Vraylar, Ubrelvy |
| Novo Nordisk INC | $776.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $523.38 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $481.96 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $426.02 | 2019-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.64 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $263.27 | 2019-2023 | Belsomra, Steglatro |
| Pfizer INC. | $148.22 | 2023-2025 | |
| Amarin Pharma, INC. | $124.02 | 2019-2023 | |
| Astellas Pharma US INC | $119.43 | 2020-2025 | Veozah |
| Amgen INC. | $111.93 | 2019-2024 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $103.66 | 2019-2022 | |
| Abbott Laboratories | $99.76 | 2019-2025 | Freestyle Libre 3 |
| Corium, LLC | $99.71 | 2022-2023 | Azstarys |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $98.02 | 2022-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $84.10 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.88 | 2022 | |
| Supernus Pharmaceuticals, INC. | $79.47 | 2021-2023 | Qelbree |
| Exact Sciences Corporation | $67.21 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.72 | 2022-2024 | Cycloset, Trulance, Xifaxan |
| Dexcom, INC. | $53.56 | 2024-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $50.26 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.17 | 2021-2022 | |
| Esperion Therapeutics, INC. | $45.71 | 2020 | |
| Eisai INC. | $42.59 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $42.05 | 2019-2020 | |
| Clarus Therapeutics INC. | $39.14 | 2021 | |
| Dynavax Technologies Corporation | $37.25 | 2023-2025 | Heplisav-B |
| Radius Health, INC. | $35.00 | 2019 | |
| Medtronic, INC. | $34.14 | 2021 | |
| Coloplast Corp | $33.40 | 2021 | |
| Antares Pharma, INC. | $31.55 | 2021-2024 | Xyosted |
| Genentech USA, INC. | $29.43 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $27.50 | 2023 | Edarbyclor |
| Valeritas, INC. | $24.56 | 2019 | |
| Alk-Abello, INC | $23.64 | 2023 | Grastek, Odactra, Ragwitek |
| Philips North America LLC | $21.55 | 2024 | (Ck7) Extended Holter |
| Recor Medical INC | $20.60 | 2025 | Paradise Ultrasound Renal Denervation System |
| Lundbeck LLC | $20.50 | 2023 | Vyepti |
| Inari Medical, INC. | $19.36 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Spr Therapeutics, INC | $18.05 | 2024 | Sprint Pns System |
| Nestle Healthcare Nutrition INC. | $17.83 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.06 | 2019 | |
| Ibsa Pharma INC. | $16.29 | 2023 | Tirosint, Licart |
| Allergan, INC. | $16.11 | 2019 | |
| Inspire Medical Systems, INC. | $13.44 | 2023 | Inspire |
| Althera Pharmaceuticals LLC | $12.36 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.22 | 2021 | |
| Shire North American Group INC | $12.11 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Woolbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.